Omeros Corporation Dividends
The next dividend date for Omeros Corporation has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Omeros Corporation (OMER)
More About Omeros Corporation
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; zaltenibart that is in phase 3 clinical trials for Paroxysmal nocturnal hemoglobinuria; in phase 2 clinical trial for the treatment complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Immunostimulator Combination Therapies, and Oncotoxins and Immunomodulators for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
Owning Omeros Corporation Stock on the Dividend Date
If you own Omeros Corporation stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Omeros Corporation stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Omeros Corporation stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Omeros Corporation stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Omeros Corporation dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Omeros Corporation Dividends
You can contact us any time if you would like to ask questions about Omeros Corporation dividends or anything else related to the stock market.